专利信息

Translation Company

首页 1 2 3 4 5 6 下页尾页共 115 条记录, 当前第1/12页。

专利标题：Synthesis process of phentolamine mesilate

专利标题：Method for preparing phentolamine mesilate freeze-drying powder injection

专利标题：COMPOSITIONS AND METHODS FOR CONTROLLING PUPIL DILATION COMPRISING PHENTOLAMINE

专利权人：ALLERGAN INC [US];

专利标题：The phentolamine mesylate fructose composite

专利标题：Compositions and methods for controlling pupil dilation comprising phentolamine

专利权人：ALLERGAN INC;

专利标题：COMPOSITIONS AND METHODS FOR CONTROLLING PUPIL DILATION

专利权人：ALLERGAN INC [US];

专利标题：A kind of external preparation that contains phentolamine and preparation method thereof

专利权人：Fudan University;

专利标题：COMPOSITIONS AND METHODS FOR CONTROLLING PUPIL DILATION COMPRISING PHENTOLAMINE

专利权人：ALLERGAN INC [US];

专利标题：COMPOSITIONS AND METHODS FOR CONTROLLING PUPIL DILATION COMPRISING PHENTOLAMINE

The disclosure provides a composition for controlling pupil dilation comprising about 0.001% to about 1.0% by weight of an alpha-adrenergic receptor antagonist selected from phentolamine, phentolamine mesylate, or a phentolamine salt;and at least one excipient selected from the group consisting of a buffer, tonicity agent, preservative, antioxidant, surfactant, solubilizer, cosolvent, and a combination thereof. A method of controlling pupil dilation in a subject in need thereof, comprising admin...

当前查询条件: [药品] 包含 'Phentolamine'

	查询范围	在当前结果中查询
!	专利类型	发明实用新型外观设计
!	公开号			CN1234
!	申请号			CN1234
!	专利标题		扩展	PHARMA
!	专利权人		扩展	pfizer
	发明人
!	申请日			yyyymmdd
!	公开日			yyyymmdd
	优先权号
!	摘要		扩展	PHARMA
	IPC			A01B

1. CN103408495A	2013/11/27	CN20131268192	2013/7/1
专利标题：Synthesis process of phentolamine mesilate 专利权人：KUNSHAN SANYOU PHARMACEUTICAL MATERIAL CO LTD;

2. CN102813631B	2013/10/2	CN20121281717	2012/8/9
专利标题：Method for preparing phentolamine mesilate freeze-drying powder injection 专利权人：Shanghai Fudan Forward Pharmaceutical Co., Ltd.;

3. CN102813631A	2012/12/12	CN20121281717	2012/8/9
专利标题：Method for preparing phentolamine mesilate freeze-drying powder injection 专利权人：SHANGHAI FUDAN FORWARD PHARMACEUTICAL CO LTD;SHANGHAI FUDAN FORWARD SCIENCE & TECHNOLOGY CO LTD;

4. EP2490668A1	2012/8/29	EP20100773774	2010/10/20
专利标题：COMPOSITIONS AND METHODS FOR CONTROLLING PUPIL DILATION COMPRISING PHENTOLAMINE 专利权人：ALLERGAN INC [US];

5. CN101732330B	2012/6/27	CN20091260122	2009/12/25
专利标题：The phentolamine mesylate fructose composite 专利权人：Bengbu Bbca Medicine Science Development Co., Ltd.;

6. AU2010310788A1	2012/5/17	AU20100310788	2010/10/20
专利标题：Compositions and methods for controlling pupil dilation comprising phentolamine 专利权人：ALLERGAN INC; The disclosure provides a composition for controlling pupil dilation comprising about 0.001% to about 1.0% by weight of an alpha-adrenergic receptor antagonist selected from phentolamine, phentolamine mesylate, or a phentolamine salt

7. US2011178147A1	2011/7/21	US20100907719	2010/10/19
专利标题：COMPOSITIONS AND METHODS FOR CONTROLLING PUPIL DILATION 专利权人：ALLERGAN INC [US]; The disclosure provides a composition for controlling pupil dilation comprising about 0.001% to about 1.0% by weight of an alpha-adrenergic receptor antagonist selected from phentolamine, phentolamine mesylate, or a phentolamine salt

8. CN101361725B	2011/5/18	CN20081215017	2008/9/2
专利标题：A kind of external preparation that contains phentolamine and preparation method thereof 专利权人：Fudan University;

9. CA2778472A1	2011/4/28	CA20102778472	2010/10/20
专利标题：COMPOSITIONS AND METHODS FOR CONTROLLING PUPIL DILATION COMPRISING PHENTOLAMINE 专利权人：ALLERGAN INC [US]; The disclosure provides a composition for controlling pupil dilation comprising about 0.001% to about 1.0% by weight of an alpha-adrenergic receptor antagonist selected from phentolamine, phentolamine mesylate, or a phentolamine salt

10. WO2011050018A1	2011/4/28	WO2010US53297	2010/10/20
专利标题：COMPOSITIONS AND METHODS FOR CONTROLLING PUPIL DILATION COMPRISING PHENTOLAMINE 专利权人：ALLERGAN INC [US];LIKITLERSUANG SUKHON [US];PARASHAR AJAY P [US];PUJARA CHETAN P [US]; The disclosure provides a composition for controlling pupil dilation comprising about 0.001% to about 1.0% by weight of an alpha-adrenergic receptor antagonist selected from phentolamine, phentolamine mesylate, or a phentolamine salt;and at least one excipient selected from the group consisting of a buffer, tonicity agent, preservative, antioxidant, surfactant, solubilizer, cosolvent, and a combination thereof. A method of controlling pupil dilation in a subject in need thereof, comprising admin...

下载范围

下载内容